Erythropoieis-stimulating Agent (ESA) Therapy and Chronic Kidney Disease (CKD)

Erythropoiesis-stimulating agents (ESAs) are a group of medications that help replace a hormone called erythropoietin (EPO). If you have chronic kidney disease (CKD), your kidneys may not release enough EPO to tell your bone marrow to make enough red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.